Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)

PURPOSE. Evaluation of the use of topical cyclosporine eyedrops in the treatment of severe dry eye disease in liver transplanted patients with familial amyloidotic polyneuropathy (FAP) unresponsive to therapy with artificial tears and lacrimal plugs. A prospective clinical study of 5 patients (10 ey...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of ophthalmology 2013-03, Vol.23 (2), p.156-163
Hauptverfasser: Beirão, João M, Matos, Maria E, Beirão, Idalina B, Costa, Paulo P, Torres, Paulo A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 163
container_issue 2
container_start_page 156
container_title European journal of ophthalmology
container_volume 23
creator Beirão, João M
Matos, Maria E
Beirão, Idalina B
Costa, Paulo P
Torres, Paulo A
description PURPOSE. Evaluation of the use of topical cyclosporine eyedrops in the treatment of severe dry eye disease in liver transplanted patients with familial amyloidotic polyneuropathy (FAP) unresponsive to therapy with artificial tears and lacrimal plugs. A prospective clinical study of 5 patients (10 eyes) admitted to the Ophthalmology Department of the Centro Hospitalar do Porto with severe dry eye disease refractory to artificial tears and lacrimal plug treatments. Evaluation of the patients included best-corrected visual acuity, corneal punctuate fluorescein staining, tear break-up time, Schirmer test without anesthesia, and Ocular Surface Disease Index. Patients were observed at time 0, and at 3, 7, and 11 months. Treatment with topical cyclosporine improved all studied parameters from baseline, and in all the patients (p
doi_str_mv 10.5301/ejo.5000197
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5301_ejo_5000197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>23065854</sourcerecordid><originalsourceid>FETCH-LOGICAL-c289t-cfe3c7691859d0bbe931b185967d9cb18aaa299cf4e35192c1799df6dfcd9c083</originalsourceid><addsrcrecordid>eNo9kEtLxDAUhYMojo6u3EuWinRM0tdkOQy-YESR6rak6Y2TIW1K0ir9Ef5nM8zo6p7L-TiLD6ELSmZpTOgtbOwsJYRQnh-gE5qzJMoIzQ5DpoxEWc7oBJ16vyGEEZ6wYzRhMcnSeZqcoJ_CdloKg-UojfWddboFrKzDHr7AAa7diGEMV3sQHrBusdGhiXonWt8Z0fZQ41fr-uFzgAB0otfQ9h5_636NlWi00WFfNKOxura9lrizZmxhcDaw6xFfLYri7SMmz9dn6EgJ4-F8f6fo_f6uWD5Gq5eHp-ViFUk2530kFcQyzzidp7wmVQU8ptX2yfKay5CEEIxzqRKIU8qZpDnntcpqJUNP5vEU3ex2pbPeO1Bl53Qj3FhSUm6llkFquZca6Msd3Q1VA_U_-2cx_gV5BnZR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Beirão, João M ; Matos, Maria E ; Beirão, Idalina B ; Costa, Paulo P ; Torres, Paulo A</creator><creatorcontrib>Beirão, João M ; Matos, Maria E ; Beirão, Idalina B ; Costa, Paulo P ; Torres, Paulo A</creatorcontrib><description>PURPOSE. Evaluation of the use of topical cyclosporine eyedrops in the treatment of severe dry eye disease in liver transplanted patients with familial amyloidotic polyneuropathy (FAP) unresponsive to therapy with artificial tears and lacrimal plugs. A prospective clinical study of 5 patients (10 eyes) admitted to the Ophthalmology Department of the Centro Hospitalar do Porto with severe dry eye disease refractory to artificial tears and lacrimal plug treatments. Evaluation of the patients included best-corrected visual acuity, corneal punctuate fluorescein staining, tear break-up time, Schirmer test without anesthesia, and Ocular Surface Disease Index. Patients were observed at time 0, and at 3, 7, and 11 months. Treatment with topical cyclosporine improved all studied parameters from baseline, and in all the patients (p&lt;0.001). The safety profile was excellent, without topical or systemic adverse events. Topical cyclosporine was beneficial in the treatment of severe dry eye disease in liver transplanted patients with FAP.</description><identifier>ISSN: 1120-6721</identifier><identifier>EISSN: 1724-6016</identifier><identifier>DOI: 10.5301/ejo.5000197</identifier><identifier>PMID: 23065854</identifier><language>eng</language><publisher>United States</publisher><subject>Administration, Topical ; Adult ; Amyloid - genetics ; Amyloid Neuropathies, Familial - epidemiology ; Amyloid Neuropathies, Familial - genetics ; Amyloid Neuropathies, Familial - surgery ; Cyclosporine - administration &amp; dosage ; Cyclosporine - therapeutic use ; Female ; Fluorescein - metabolism ; Humans ; Immunosuppressive Agents - administration &amp; dosage ; Immunosuppressive Agents - therapeutic use ; Keratoconjunctivitis Sicca - drug therapy ; Keratoconjunctivitis Sicca - physiopathology ; Liver Transplantation ; Male ; Middle Aged ; Ophthalmic Solutions ; Portugal - epidemiology ; Prealbumin - genetics ; Prospective Studies ; Staining and Labeling ; Tears - physiology ; Visual Acuity - physiology</subject><ispartof>European journal of ophthalmology, 2013-03, Vol.23 (2), p.156-163</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c289t-cfe3c7691859d0bbe931b185967d9cb18aaa299cf4e35192c1799df6dfcd9c083</citedby><cites>FETCH-LOGICAL-c289t-cfe3c7691859d0bbe931b185967d9cb18aaa299cf4e35192c1799df6dfcd9c083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23065854$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Beirão, João M</creatorcontrib><creatorcontrib>Matos, Maria E</creatorcontrib><creatorcontrib>Beirão, Idalina B</creatorcontrib><creatorcontrib>Costa, Paulo P</creatorcontrib><creatorcontrib>Torres, Paulo A</creatorcontrib><title>Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)</title><title>European journal of ophthalmology</title><addtitle>Eur J Ophthalmol</addtitle><description>PURPOSE. Evaluation of the use of topical cyclosporine eyedrops in the treatment of severe dry eye disease in liver transplanted patients with familial amyloidotic polyneuropathy (FAP) unresponsive to therapy with artificial tears and lacrimal plugs. A prospective clinical study of 5 patients (10 eyes) admitted to the Ophthalmology Department of the Centro Hospitalar do Porto with severe dry eye disease refractory to artificial tears and lacrimal plug treatments. Evaluation of the patients included best-corrected visual acuity, corneal punctuate fluorescein staining, tear break-up time, Schirmer test without anesthesia, and Ocular Surface Disease Index. Patients were observed at time 0, and at 3, 7, and 11 months. Treatment with topical cyclosporine improved all studied parameters from baseline, and in all the patients (p&lt;0.001). The safety profile was excellent, without topical or systemic adverse events. Topical cyclosporine was beneficial in the treatment of severe dry eye disease in liver transplanted patients with FAP.</description><subject>Administration, Topical</subject><subject>Adult</subject><subject>Amyloid - genetics</subject><subject>Amyloid Neuropathies, Familial - epidemiology</subject><subject>Amyloid Neuropathies, Familial - genetics</subject><subject>Amyloid Neuropathies, Familial - surgery</subject><subject>Cyclosporine - administration &amp; dosage</subject><subject>Cyclosporine - therapeutic use</subject><subject>Female</subject><subject>Fluorescein - metabolism</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Keratoconjunctivitis Sicca - drug therapy</subject><subject>Keratoconjunctivitis Sicca - physiopathology</subject><subject>Liver Transplantation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Ophthalmic Solutions</subject><subject>Portugal - epidemiology</subject><subject>Prealbumin - genetics</subject><subject>Prospective Studies</subject><subject>Staining and Labeling</subject><subject>Tears - physiology</subject><subject>Visual Acuity - physiology</subject><issn>1120-6721</issn><issn>1724-6016</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLxDAUhYMojo6u3EuWinRM0tdkOQy-YESR6rak6Y2TIW1K0ir9Ef5nM8zo6p7L-TiLD6ELSmZpTOgtbOwsJYRQnh-gE5qzJMoIzQ5DpoxEWc7oBJ16vyGEEZ6wYzRhMcnSeZqcoJ_CdloKg-UojfWddboFrKzDHr7AAa7diGEMV3sQHrBusdGhiXonWt8Z0fZQ41fr-uFzgAB0otfQ9h5_636NlWi00WFfNKOxura9lrizZmxhcDaw6xFfLYri7SMmz9dn6EgJ4-F8f6fo_f6uWD5Gq5eHp-ViFUk2530kFcQyzzidp7wmVQU8ptX2yfKay5CEEIxzqRKIU8qZpDnntcpqJUNP5vEU3ex2pbPeO1Bl53Qj3FhSUm6llkFquZca6Msd3Q1VA_U_-2cx_gV5BnZR</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Beirão, João M</creator><creator>Matos, Maria E</creator><creator>Beirão, Idalina B</creator><creator>Costa, Paulo P</creator><creator>Torres, Paulo A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20130301</creationdate><title>Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)</title><author>Beirão, João M ; Matos, Maria E ; Beirão, Idalina B ; Costa, Paulo P ; Torres, Paulo A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c289t-cfe3c7691859d0bbe931b185967d9cb18aaa299cf4e35192c1799df6dfcd9c083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Administration, Topical</topic><topic>Adult</topic><topic>Amyloid - genetics</topic><topic>Amyloid Neuropathies, Familial - epidemiology</topic><topic>Amyloid Neuropathies, Familial - genetics</topic><topic>Amyloid Neuropathies, Familial - surgery</topic><topic>Cyclosporine - administration &amp; dosage</topic><topic>Cyclosporine - therapeutic use</topic><topic>Female</topic><topic>Fluorescein - metabolism</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Keratoconjunctivitis Sicca - drug therapy</topic><topic>Keratoconjunctivitis Sicca - physiopathology</topic><topic>Liver Transplantation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Ophthalmic Solutions</topic><topic>Portugal - epidemiology</topic><topic>Prealbumin - genetics</topic><topic>Prospective Studies</topic><topic>Staining and Labeling</topic><topic>Tears - physiology</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beirão, João M</creatorcontrib><creatorcontrib>Matos, Maria E</creatorcontrib><creatorcontrib>Beirão, Idalina B</creatorcontrib><creatorcontrib>Costa, Paulo P</creatorcontrib><creatorcontrib>Torres, Paulo A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>European journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beirão, João M</au><au>Matos, Maria E</au><au>Beirão, Idalina B</au><au>Costa, Paulo P</au><au>Torres, Paulo A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)</atitle><jtitle>European journal of ophthalmology</jtitle><addtitle>Eur J Ophthalmol</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>23</volume><issue>2</issue><spage>156</spage><epage>163</epage><pages>156-163</pages><issn>1120-6721</issn><eissn>1724-6016</eissn><abstract>PURPOSE. Evaluation of the use of topical cyclosporine eyedrops in the treatment of severe dry eye disease in liver transplanted patients with familial amyloidotic polyneuropathy (FAP) unresponsive to therapy with artificial tears and lacrimal plugs. A prospective clinical study of 5 patients (10 eyes) admitted to the Ophthalmology Department of the Centro Hospitalar do Porto with severe dry eye disease refractory to artificial tears and lacrimal plug treatments. Evaluation of the patients included best-corrected visual acuity, corneal punctuate fluorescein staining, tear break-up time, Schirmer test without anesthesia, and Ocular Surface Disease Index. Patients were observed at time 0, and at 3, 7, and 11 months. Treatment with topical cyclosporine improved all studied parameters from baseline, and in all the patients (p&lt;0.001). The safety profile was excellent, without topical or systemic adverse events. Topical cyclosporine was beneficial in the treatment of severe dry eye disease in liver transplanted patients with FAP.</abstract><cop>United States</cop><pmid>23065854</pmid><doi>10.5301/ejo.5000197</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1120-6721
ispartof European journal of ophthalmology, 2013-03, Vol.23 (2), p.156-163
issn 1120-6721
1724-6016
language eng
recordid cdi_crossref_primary_10_5301_ejo_5000197
source MEDLINE; SAGE Complete
subjects Administration, Topical
Adult
Amyloid - genetics
Amyloid Neuropathies, Familial - epidemiology
Amyloid Neuropathies, Familial - genetics
Amyloid Neuropathies, Familial - surgery
Cyclosporine - administration & dosage
Cyclosporine - therapeutic use
Female
Fluorescein - metabolism
Humans
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - therapeutic use
Keratoconjunctivitis Sicca - drug therapy
Keratoconjunctivitis Sicca - physiopathology
Liver Transplantation
Male
Middle Aged
Ophthalmic Solutions
Portugal - epidemiology
Prealbumin - genetics
Prospective Studies
Staining and Labeling
Tears - physiology
Visual Acuity - physiology
title Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T01%3A08%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topical%20cyclosporine%20for%20severe%20dry%20eye%20disease%20in%20liver-transplanted%20Portuguese%20patients%20with%20familial%20amyloidotic%20polyneuropathy%20(ATTRV30M)&rft.jtitle=European%20journal%20of%20ophthalmology&rft.au=Beir%C3%A3o,%20Jo%C3%A3o%20M&rft.date=2013-03-01&rft.volume=23&rft.issue=2&rft.spage=156&rft.epage=163&rft.pages=156-163&rft.issn=1120-6721&rft.eissn=1724-6016&rft_id=info:doi/10.5301/ejo.5000197&rft_dat=%3Cpubmed_cross%3E23065854%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/23065854&rfr_iscdi=true